Concepedia

Jake Goodwin‐Tindall

JG

Statistics

Publications

5

Citations

262

H-Index

5

Active since

2015

Affiliations

University of Dundee(Current)

University of York

Technical University of Munich

Boehringer Ingelheim (Austria)

Boehringer Ingelheim (United States)

Jake Goodwin‐Tindall is an author at University of Dundee specializing in medicinal chemistry, enzyme inhibition, and pharmacology.

Publications per year

2015–2024

5

Publications

5

Targeting cancer with small-molecule pan-KRAS degraders

Johannes Popow, William Farnaby, Andreas Gollner et al. · Science · 2024 · 158 citations · Full text

, , +15

A Convenient Approach to Stereoisomeric Iminocyclitols: Generation of Potent Brain‐Permeable OGA Inhibitors

Milan Bergeron‐Brlek, Jake Goodwin‐Tindall, Nevena Cekic et al. · Angewandte Chemie International Edition · 2015 · 47 citations · Full text

, , +15

Identification of Potent Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors Based on a Phenylimidazole Scaffold

Michael G. Brant, Jake Goodwin‐Tindall, Kurt R. Stover et al. · ACS Medicinal Chemistry Letters · 2018 · 32 citations · Full text

, , +17

Targeting cancer with small molecule pan-KRAS degraders

Johannes Popow, William Farnaby, Andreas Gollner et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2023 · 15 citations · Full text

, , +14

A Convenient Approach to Stereoisomeric Iminocyclitols: Generation of Potent Brain‐Permeable OGA Inhibitors

Milan Bergeron‐Brlek, Jake Goodwin‐Tindall, Nevena Cekic et al. · Angewandte Chemie · 2015 · 10 citations

, , +15

1–5 of 5